Combination Therapy of PPAR𝛾 Ligands and Inhibitors of Arachidonic Acid in Lung Cancer
Lung cancer is the leading cause of cancer death in the United States and five-year survival remains low. Numerous studies have shown that chronic inflammation may lead to progression of carcinogenesis. As a result of inflammatory stimulation, arachidonic acid (AA) metabolism produces proliferation...
Saved in:
Main Authors: | Jordi Tauler, James L. Mulshine |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2008/750238 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPAR𝛾, PTEN, and the Fight against Cancer
by: Rosemary E. Teresi, et al.
Published: (2008-01-01) -
LPCAT3 regulates the proliferation and metastasis of serous ovarian cancer by modulating arachidonic acid
by: Fang Wen, et al.
Published: (2025-02-01) -
Arachidonic Acid Derivatives and Their Role in Peripheral Nerve Degeneration and Regeneration
by: Carlos Rodrigo Camara-Lemarroy, et al.
Published: (2012-01-01) -
Metabolic pathways of eicosanoids—derivatives of arachidonic acid and their significance in skin
by: Michał Biernacki, et al.
Published: (2025-01-01) -
Incorporation and Effect of Arachidonic Acid on the Growth of Human Myeloma Cell Lines
by: V. Desplat, et al.
Published: (1999-01-01)